Most HIV patients need to take daily anti-retroviral therapy — if they suspend treatment, HIV will rebound within 3-4 weeks. But clinical trials have revealed that a small
Differences in the DNA within the mitochondria, the energy-producing structures within cells, can determine the severity and progression of heart disease caused by a nuclear DNA mutation. A
Architects cannot build a house without the proper dimensions of the foundation. Likewise, scientists cannot develop targeted drug therapies without first measuring the surfaces of biomolecules such as
How can the world achieve the deep carbon emissions reductions that are necessary to slow or reverse the impacts of climate change? The authors of a new MIT
A drug policy researcher is proposing a suite of changes to overhaul the Multi-Criteria Drug Harm Scale (MCDHS), which informs drug policies across Europe. The changes focus on
America’s drug problem may be even worse than officials realize. And illicit drugs are consumed at a higher rate during celebratory events. Those are just two of the
In a randomized, Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, the PARP inhibitor talazoparib extended progression-free survival (PFS) and improved
A new comprehensive natural history study about Amish nemaline myopathy (ANM) in the Old Order Amish population focuses on the promise of gene therapy for this lethal disorder.
A team led by scientists from the Johns Hopkins Bloomberg School of Public Health has sequenced and annotated the first complete mitochondrial genome of Anopheles funestus, one of
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok
